Extended Data Table 1.
Characteristics of patients and transplant course.
| Parameter | No. (% of patients) |
|---|---|
| Age (years) | |
| ≤29 | 2/24 (8.3%) |
| 30–39 | 5/24 (20.8%) |
| 40–49 | 2/24 (8.3%) |
| 50–59 | 6/24 (25.0%) |
| ≥60 | 9/24 (37.5%) |
| Sex (female) | 10/24 (41.7%) |
| Underlying Disease | |
| Leukemia | 11/24 (45.8%) |
| Lymphoma | 5/24 (20.8%) |
| Multiple Myeloma | 3/24 (12.5%) |
| Myelodysplastic Syndrome | 3/24 (12.5%) |
| Other | 2/24 (8.3%) |
| Conditioning Intensity | |
| Nonmyeloablative | 4/24 (16.7%) |
| Reduced intensity | 4/24 (16.7%) |
| Myeloablative | 16/24 (66.7%) |
| T-call depletion | 13/24 (54.2%) |
| Stem cell source (cord vs. other) | 5/24 (20.8%) |
| Time to engraftment (≥l4d)a,b | 5/24 (20.8%) |
| Fever (T≥100.4)b | 21/24 (87.5%) |
| Vital Status: Deadb | 1/24 (4.2%) |
| Total | 24/24 (100.0%) |
a
Engraftment was defined as an absolute neutrophil count of >500 cells/μL for 3 consecutive days.
b
Assessed during inpatient allogeneic hematopoietic stem cell transplantation hospitalization (from 15 days before transplant to 35 days after transplant).